US Lawmakers Say WHO Opioid Guidelines Too Lax
Organization claims guidelines influenced by people with financial ties to Purdue Pharma.
Pain Management
Usual Care vs Restrictive Strategy to Reduce Abdominal Pain in Patients With Gallstones
Patients who underwent cholecystectomy with either a usual care approach or a more restrictive selection strategy experienced a suboptimal reduction in abdominal pain.
FDA Launches “Remove the Risk” Campaign for Safe Disposal of Unused Opioids
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
CDC Provides Clarification of Opioid Prescribing Guideline
Misapplication of the guideline can put patient health and safety at risk.
FDA Approves First Generic Nasal Spray Against Opioid Overdose
The first generic naloxone nasal spray to treat opioid overdose has received approval from the US Food and Drug Administration.
Opioid Prescription of 4 to 7 Days May Be Sufficient for Acute Pain Management
An initial prescription of opioids for 4 to 7 days for the management of acute pain in the primary care setting was found to be sufficient.
Psychological Treatments Show Efficacy in Primary Headache Disorder
Researchers found data to support psychological treatments to reduce the number of headaches and the headache index.
Opioid Prescriptions Dropped for New Users From 2012 to 2017
Many providers stopped initiating opioid therapy from July 2012 to December 2017.
Benzodiazepines: Primary Care’s New Drug Problem
Curtailing prescription opioid use has led to an increase in prescribing benzodiazepines to manage pain.
HHS Task Force Issues Draft Report on Best Practices for Pain Management
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
Next post in Pain Management Information Center
